PL1818059T3 - Środek do zapobiegania lub do leczenia jaskry - Google Patents
Środek do zapobiegania lub do leczenia jaskryInfo
- Publication number
- PL1818059T3 PL1818059T3 PL05819681T PL05819681T PL1818059T3 PL 1818059 T3 PL1818059 T3 PL 1818059T3 PL 05819681 T PL05819681 T PL 05819681T PL 05819681 T PL05819681 T PL 05819681T PL 1818059 T3 PL1818059 T3 PL 1818059T3
- Authority
- PL
- Poland
- Prior art keywords
- glaucoma
- therapeutic agent
- preventive
- salt
- preventing
- Prior art date
Links
- 208000010412 Glaucoma Diseases 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 3
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 title 1
- 206010030043 Ocular hypertension Diseases 0.000 abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 230000004410 intraocular pressure Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 230000004493 normal intraocular pressure Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63811804P | 2004-12-23 | 2004-12-23 | |
| PCT/JP2005/023570 WO2006068208A1 (ja) | 2004-12-23 | 2005-12-22 | 緑内障予防又は治療剤 |
| EP05819681A EP1818059B1 (en) | 2004-12-23 | 2005-12-22 | Preventive or therapeutic agent for glaucoma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1818059T3 true PL1818059T3 (pl) | 2009-05-29 |
Family
ID=36601805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05819681T PL1818059T3 (pl) | 2004-12-23 | 2005-12-22 | Środek do zapobiegania lub do leczenia jaskry |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1818059B1 (pl) |
| JP (1) | JP4099201B2 (pl) |
| KR (1) | KR101286813B1 (pl) |
| CN (1) | CN101087613B (pl) |
| AT (1) | ATE415972T1 (pl) |
| AU (1) | AU2005320085B2 (pl) |
| BR (1) | BRPI0519007A2 (pl) |
| CA (1) | CA2585372A1 (pl) |
| CY (1) | CY1108651T1 (pl) |
| DE (1) | DE602005011476D1 (pl) |
| DK (1) | DK1818059T3 (pl) |
| EA (1) | EA011085B1 (pl) |
| ES (1) | ES2317338T3 (pl) |
| MX (1) | MX2007007614A (pl) |
| MY (1) | MY138811A (pl) |
| NO (1) | NO20072187L (pl) |
| NZ (1) | NZ555137A (pl) |
| PL (1) | PL1818059T3 (pl) |
| PT (1) | PT1818059E (pl) |
| SI (1) | SI1818059T1 (pl) |
| TW (1) | TWI367098B (pl) |
| WO (1) | WO2006068208A1 (pl) |
| ZA (1) | ZA200704874B (pl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007007879A1 (ja) * | 2005-07-14 | 2007-01-18 | Sharp Kabushiki Kaisha | 表示素子、及びこれを用いた電気機器 |
| CN102099037A (zh) | 2008-07-25 | 2011-06-15 | 旭化成制药株式会社 | 含有磺酰胺化合物的稳定的水溶液组合物 |
| CN103338772A (zh) * | 2011-02-04 | 2013-10-02 | 兴和株式会社 | 用于预防或治疗青光眼的药物疗法 |
| EA026904B1 (ru) * | 2012-11-23 | 2017-05-31 | Игорь Михайлович Юхт | Способ количественного определения полигексаметиленбигуанидина (пгмб) гидрохлорида в составах для приготовления жидких лекарственных средств для лечения заболеваний глаз и носа (2 варианта) |
| US20160339018A1 (en) * | 2013-04-24 | 2016-11-24 | Kyushu University, National University Corporation | Therapeutic agent for ocular fundus disease |
| MX377963B (es) | 2014-09-25 | 2025-03-10 | Kowa Co | Composición acuosa. |
| MY179721A (en) * | 2014-09-25 | 2020-11-11 | Kowa Co | Pharmaceutical product |
| TWI699205B (zh) * | 2014-12-12 | 2020-07-21 | 日商興和股份有限公司 | 用於預防或治療青光眼之藥物療法 |
| MY178881A (en) | 2014-12-12 | 2020-10-21 | Kowa Co | Novel aqueous composition |
| KR20160108121A (ko) | 2015-03-06 | 2016-09-19 | 코와 가부시키가이샤 | 수성 조성물 |
| JP2018118905A (ja) * | 2015-04-27 | 2018-08-02 | 恵 本庄 | 白内障術後合併症の予防治療剤 |
| CN106310285A (zh) * | 2015-06-15 | 2017-01-11 | 江苏吉贝尔药业股份有限公司 | 一种新的盐酸利舒地尔滴眼液及其制备方法 |
| JP6886322B2 (ja) * | 2016-03-25 | 2021-06-16 | 興和株式会社 | 眼科用組成物 |
| CN107164328A (zh) * | 2017-06-30 | 2017-09-15 | 太仓卡斯特姆新材料有限公司 | 一种高稳定性mcf‑7乳腺癌细胞的复苏方法 |
| CA3086457A1 (en) | 2017-12-21 | 2019-06-27 | Santen Pharmaceutical Co., Ltd. | Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor |
| JP2020193174A (ja) * | 2019-05-29 | 2020-12-03 | 興和株式会社 | 水性組成物 |
| EP4274578A1 (en) | 2021-01-11 | 2023-11-15 | Incyte Corporation | Combination therapy comprising jak pathway inhibitor and rock inhibitor |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9401108D0 (sv) * | 1994-03-31 | 1994-03-31 | Leiras Oy | Ophthalmic composition I |
| DE19512639A1 (de) * | 1995-04-05 | 1996-10-10 | Merck Patent Gmbh | Benzonitrile und -fluoride |
| PT868186E (pt) * | 1995-12-21 | 2005-05-31 | Alcon Lab Inc | Utilizacao de certos compostos de isoquinolinossulfonilo para tratamento de glaucoma e isquemia ocular |
| JPH10310576A (ja) * | 1997-03-10 | 1998-11-24 | Hiroyoshi Hidaka | イソキノリンスルフォンアミド誘導体及びこれを有効成分とする医薬 |
| EP0977756A1 (en) * | 1997-04-25 | 2000-02-09 | Pfizer Limited | PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| FR2777189B1 (fr) | 1998-04-09 | 2001-04-06 | Chauvin Lab Sa | Composition ophtalmique comprenant un beta-bloquant |
| CA2327276A1 (en) * | 1998-04-23 | 1999-10-28 | Hiroshi Muramatsu | Isoquinolinesulfonamide derivatives and drugs containing the same as the active ingredient |
| JP4212149B2 (ja) * | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 医薬 |
| AU5198199A (en) | 1998-08-17 | 2000-03-06 | Senju Pharmaceutical Co., Ltd. | Preventives/remedies for glaucoma |
| OA11665A (en) * | 1998-10-22 | 2004-12-08 | Neurosearch As | Substituted phenyl derivatives, their preparation and use. |
-
2005
- 2005-12-13 TW TW094144075A patent/TWI367098B/zh not_active IP Right Cessation
- 2005-12-14 MY MYPI20055888A patent/MY138811A/en unknown
- 2005-12-22 DK DK05819681T patent/DK1818059T3/da active
- 2005-12-22 PL PL05819681T patent/PL1818059T3/pl unknown
- 2005-12-22 NZ NZ555137A patent/NZ555137A/en not_active IP Right Cessation
- 2005-12-22 EP EP05819681A patent/EP1818059B1/en not_active Expired - Lifetime
- 2005-12-22 JP JP2006549049A patent/JP4099201B2/ja not_active Expired - Lifetime
- 2005-12-22 EA EA200701134A patent/EA011085B1/ru not_active IP Right Cessation
- 2005-12-22 ZA ZA200704874A patent/ZA200704874B/xx unknown
- 2005-12-22 AT AT05819681T patent/ATE415972T1/de active
- 2005-12-22 CN CN2005800444266A patent/CN101087613B/zh not_active Expired - Fee Related
- 2005-12-22 KR KR1020077012207A patent/KR101286813B1/ko not_active Expired - Fee Related
- 2005-12-22 AU AU2005320085A patent/AU2005320085B2/en not_active Ceased
- 2005-12-22 WO PCT/JP2005/023570 patent/WO2006068208A1/ja not_active Ceased
- 2005-12-22 MX MX2007007614A patent/MX2007007614A/es active IP Right Grant
- 2005-12-22 CA CA002585372A patent/CA2585372A1/en not_active Abandoned
- 2005-12-22 SI SI200530540T patent/SI1818059T1/sl unknown
- 2005-12-22 BR BRPI0519007-0A patent/BRPI0519007A2/pt not_active IP Right Cessation
- 2005-12-22 DE DE602005011476T patent/DE602005011476D1/de not_active Expired - Lifetime
- 2005-12-22 PT PT05819681T patent/PT1818059E/pt unknown
- 2005-12-22 ES ES05819681T patent/ES2317338T3/es not_active Expired - Lifetime
-
2007
- 2007-04-27 NO NO20072187A patent/NO20072187L/no not_active Application Discontinuation
-
2008
- 2008-12-11 CY CY20081101444T patent/CY1108651T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1113312A1 (zh) | 2008-10-03 |
| KR20070090897A (ko) | 2007-09-06 |
| EP1818059B1 (en) | 2008-12-03 |
| AU2005320085A1 (en) | 2006-06-29 |
| WO2006068208A1 (ja) | 2006-06-29 |
| PT1818059E (pt) | 2008-12-31 |
| KR101286813B1 (ko) | 2013-07-17 |
| CY1108651T1 (el) | 2014-04-09 |
| BRPI0519007A2 (pt) | 2008-12-23 |
| ZA200704874B (en) | 2008-08-27 |
| DE602005011476D1 (de) | 2009-01-15 |
| JPWO2006068208A1 (ja) | 2008-06-12 |
| JP4099201B2 (ja) | 2008-06-11 |
| EP1818059A1 (en) | 2007-08-15 |
| TW200628160A (en) | 2006-08-16 |
| EA200701134A1 (ru) | 2007-10-26 |
| SI1818059T1 (sl) | 2009-04-30 |
| EA011085B1 (ru) | 2008-12-30 |
| ES2317338T3 (es) | 2009-04-16 |
| MX2007007614A (es) | 2007-08-15 |
| ATE415972T1 (de) | 2008-12-15 |
| DK1818059T3 (da) | 2009-03-16 |
| MY138811A (en) | 2009-07-31 |
| CN101087613A (zh) | 2007-12-12 |
| TWI367098B (en) | 2012-07-01 |
| EP1818059A4 (en) | 2007-12-26 |
| NO20072187L (no) | 2007-07-13 |
| NZ555137A (en) | 2009-10-30 |
| CN101087613B (zh) | 2010-08-18 |
| AU2005320085B2 (en) | 2010-07-29 |
| CA2585372A1 (en) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072187L (no) | Preventivt eller terapeutisk middel for glaucom | |
| WO2007076360A8 (en) | (indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)- pyrazines for treating rho kinase-mediated diseases and conditions | |
| PL378030A1 (pl) | Czynniki które regulują, hamują lub modulują działanie i/lub wyrażanie czynnika wzrostowego tkanki łącznej (CTGF), jako wyjątkowe środki do obniżania ciśnienia śródgałkowego i leczenia retinopatii jaskrowej/neuropatii nerwu wzrokowego | |
| WO2006066103A3 (en) | Ophthalmic implant for treatment of glaucoma | |
| WO2002080811A3 (en) | Glaucoma stent and methods thereof for glaucoma treatment | |
| AU2003274734A1 (en) | Method and composition containing latanoprost for treating ocular hypertension and glaucoma | |
| WO2003005941A3 (de) | Insert zur behandlung des trockenen auges | |
| WO2008070726A3 (en) | Treatment for dry eye | |
| AU5198199A (en) | Preventives/remedies for glaucoma | |
| WO2002098350A3 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
| WO2007126364A8 (en) | Use of antisecretory factors for treating intraocular hypertension | |
| WO2004069181A3 (en) | Composition for the treatment of intraocular pressure | |
| WO2007076367A3 (en) | Rnai-mediated inhibition of rho kinase for treatment of ocular hypertension / glaucoma | |
| WO2005027884A3 (en) | Stabilized ocular solutions | |
| WO2007127711A3 (en) | Abnormal cannabidiols as agents for lowering intraocular pressure | |
| ZA200607988B (en) | Statins for the treatment of ocular hypertension and glaucoma | |
| MX2008015976A (es) | Tratamiento topico para enfermedades de superficie ocular. | |
| EP1482922A4 (en) | AGENTS FOR CORNEAL OR INTRASTROMAL ADMINISTRATION FOR TREATING OR PREVENTING OCULAR DISORDERS | |
| WO2005021026A3 (en) | Methods for treating or ameliorating ghrelin-associated diseases and disorders | |
| MXPA04001255A (es) | Uso de compuesto para el tratamiento de condiciones que resultan de lesion al nervio corneo despues de lasik y otras cirugias oculares o trauma. | |
| WO2006020003A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
| TW200806284A (en) | Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma | |
| WO2003101379A3 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
| WO2006061525A3 (fr) | Compositions pour le traitement des pathologies oculaires de surface | |
| WO2002060339A3 (en) | Ophthalmic compositions for treating ocular hypertension |